Upgrade to SI Premium - Free Trial

Canaccord on Guardant Health (GH): 'not concerned by CMO resignation'

April 28, 2026 12:56 PM
Canaccord analyst Kyle Mikson reiterated a Buy rating and $135.00 price target on Guardant Health (NASDAQ: GH)The analyst commented, "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments